ECYT : Summary for Endocyte, Inc. - Yahoo Finance

U.S. Markets close in 4 hrs 32 mins

Endocyte, Inc. (ECYT)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
2.09+0.05 (+2.45%)
As of 11:22AM EST. Market open.
People also watch
ACRXINFIEPZMCCXIMACK
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close2.04
Open2.06
Bid2.09 x 800
Ask2.11 x 3400
Day's Range2.06 - 2.12
52 Week Range1.98 - 4.33
Volume35,931
Avg. Volume217,240
Market Cap88.34M
Beta1.50
PE Ratio (TTM)-2.07
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Endocyte (ECYT) to Post Q4 Earnings: What's in the Cards?
    Zacks4 days ago

    Endocyte (ECYT) to Post Q4 Earnings: What's in the Cards?

    Endocyte, Inc (ECYT) is expected to report fourth-quarter 2016 results on Mar 1. The company has an impressive track record, having beaten estimates on three of the trailing four quarters and reporting in-line results in the remaining quarter

  • Valeant Streamlines Portfolio with Skincare Brands Sale
    Zacks2 months ago

    Valeant Streamlines Portfolio with Skincare Brands Sale

    Beleaguered Valeant Pharmaceuticals International, Inc. (VRX) announced that it has entered into an agreement to sell its CeraVe, AcneFree and AMBI skincare brands to L'Or??al for $1.3 billion in cash.

  • Valeant to Sell Dendreon Unit to Sanpower for $820 Million
    Zacks2 months ago

    Valeant to Sell Dendreon Unit to Sanpower for $820 Million

    Beleaguered Valeant Pharmaceuticals International, Inc. (VRX) announced that it will sell all the outstanding equity interests in Dendreon Pharmaceuticals, Inc. to the China based Sanpower Group Co., Ltd.